April 13, 2018 / 4:06 PM / 5 months ago

BRIEF-Vanda Pharmaceuticals Wins Appeal Case On Fanapt

April 13 (Reuters) - Vanda Pharmaceuticals Inc :

* VANDA WINS APPEAL CASE ON FANAPT®

* U.S. FEDERAL COURT AFFIRMED U.S. COURT’S DECISION THAT WEST WARD PHARMACEUTICALS INFRINGED CO’S U.S. ‘610 PATENT FOR FANAPT

* ‘610 PATENT IS SET TO EXPIRE NOVEMBER 2, 2027 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below